95 related articles for article (PubMed ID: 2411391)
1. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract][Full Text] [Related]
2. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
4. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
[TBL] [Abstract][Full Text] [Related]
7. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
8. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
Hamby CV; Liao SK; Kanamaru T; Ferrone S
Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
[TBL] [Abstract][Full Text] [Related]
10. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
14. New monoclonal antibodies against colon cancer-associated antigens.
Drewinko B; Yang LY; Chan J; Trujillo JM
Cancer Res; 1986 Oct; 46(10):5137-43. PubMed ID: 2428473
[TBL] [Abstract][Full Text] [Related]
15. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
Mujoo K; Rosenblum MG; Murray JL
Cancer Res; 1991 Jun; 51(11):2768-72. PubMed ID: 2032216
[TBL] [Abstract][Full Text] [Related]
16. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells.
Natali PG; Wilson BS; Imai K; Bigotti A; Ferrone S
Cancer Res; 1982 Feb; 42(2):583-9. PubMed ID: 6173115
[TBL] [Abstract][Full Text] [Related]
18. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.
Natali PG; Imai K; Wilson BS; Bigotti A; Cavaliere R; Pellegrino MA; Ferrone S
J Natl Cancer Inst; 1981 Sep; 67(3):591-601. PubMed ID: 6944531
[TBL] [Abstract][Full Text] [Related]
19. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
20. Malignant human B cells express two populations of p24 surface antigens.
Pesando JM; Hoffman P; Conrad T
J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
